from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1622c/cydB

LFCtreatmentdescriptionclass of inhibitor

-1.069

Amikacinug/mL Amikacintranslation

-0.641

Cap5-10ug/mL Capreomycintranslation

-0.946

Rox10-50 ug/mL Roxithromycintranslation

-0.802

SM2-5 ug/mL Streptomycintranslation

-1.951

Tet5-10 ug/mL Tetracyclinetranslation

-0.374

Rif0.2-5ug/mL Rifampicintranscription

-0.079

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.492

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.788

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.556

CPZ10-50 ug/mL Chlorpromazinerespiration

1.714

Clofazimine10-13 ug/mL Clofaziminerespiration

0.727

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

2.473

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.428

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

2.182

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

1.211

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.376

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.249

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

3.695

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-1.022

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

3.500

KCN5-20 ug/mL Potassium cyaniderespiration

1.024

NaN30.2-2 mM Sodium aziderespiration

0.406

Nigericin50 uM Nigericinrespiration

0.353

TRC10-150 ug/mL Triclosanrespiration

0.083

TRZ10-25 ug/mL Thioridazinerespiration

-1.507

Valinomycin0.5-10 uM Valinomycinrespiration

0.521

ZnSO42 mM ZnSO4respiration

-0.760

menadione6-10 ug/mL Menadionerespiration

0.582

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.918

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.471

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.404

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

1.481

NRP_1Non-replicating persistence stage 1dosRassociated

-0.309

Amp0.2mg/mL AmpicillincellWall

-0.799

Cephalexin20-100 ug/mL CephalexincellWall

-0.608

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.904

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.636

EMB10-20 ug/mL EthambutolcellWall

-0.178

Eta12-40 ug/mL EthionamidecellWall

-0.715

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.210

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.447

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.516

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.452

BZA0.12 mg/mL BenzamidearomaticAmides

0.328

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.201

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.038

H2O24 mM hydrogen peroxideDNAdamaging

-0.649

Levo10 ug/mL LevofloxacinDNAdamaging

-0.327

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.096

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.835

Oflox5-10 ug/mL OfloxacinDNAdamaging

-1.032

UVUV-irradiationDNAdamaging

-0.318

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.405

Antimycin12.5-50 ug/mL Antimycin A?

-0.471

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.238

PA_110-50 ug/mL Antitubercular compound PA-1?

0.138

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.848

PA8240.2-2 ug/mL PA-824?

-0.027

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.742

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.729

Verapamil50 uM Verapamil?

-0.145

mercaptoethanol2 mM 2-Mercaptoethanol?

0.073

methoxatin10-20 ug/mL Methoxatin?